Long-Term Protocol Governance: How Stacks Should Evolve
Stacks grow and almost never shrink. Governance means deciding in advance what would cause you to remove something, then actually doing it.
The Short Answer
Supplement stacks have a characteristic failure mode: they accumulate. Each addition has a reason at the time, and no addition has an expiry date, so a stack built over five years contains items whose original justification has been forgotten, whose underlying problem has resolved, and whose evidence has weakened since. Governance is the practice of building the reverse pressure: a defined reason for each item, a defined review interval, and a willingness to remove.
Why Stacks Only Grow
Asymmetric attribution. If something improves after adding a compound, the compound gets credit. If nothing improves, the compound is rarely blamed. Both errors add items.
Loss aversion. Removing something feels like risking the gains, even where the compound was not producing them.
No expiry date. An item added for a specific problem has no mechanism that removes it when the problem resolves.
Sunk cost. A large tub encourages finishing rather than reassessing.
Identity. A stack becomes part of how someone sees themselves, which makes subtraction feel like regression.
Information asymmetry. Every commercial source has an interest in addition and none in subtraction. There is no marketing for stopping.
Recognising these is most of the work, because they are the reason a rational person ends up with eighteen items they cannot individually justify.
The Governance Rules
Every item has a written reason. What problem, which marker or symptom, what would indicate it worked. An item you cannot state a reason for is the first candidate for removal.
Every item has a category. Corrective, meaning it addresses a shortfall or problem that could resolve. Maintenance, meaning it works by an ongoing mechanism and stops working when it stops. Experimental, meaning it is on trial with an observation window. The category determines how it is reviewed.
Every addition has an observation window and a defined outcome. Three months and a specific thing you are watching. Without both, an experiment cannot conclude.
One change at a time. Two simultaneous changes make attribution impossible, which wastes the observation window.
Corrective items get removal trials. Annually at minimum, and immediately when the underlying problem resolves.
Anything without a current reason goes. Not reduced, removed, with a re-measurement to confirm nothing was lost.
New evidence can remove an item. Compounds that looked reasonable five years ago have since been tested. A stack should reflect current evidence rather than the evidence at the time of purchase.
The Review Calendar
| Interval | Action |
|---|---|
| Weekly | Glance at sleep regularity, resting heart rate, training completed. No decisions. |
| Monthly | Any new medication? Any dose creep? Any item whose reason has lapsed? |
| Quarterly | One removal trial on the least-justified item. Conclude any open observation window. |
| Annually | Full audit. Every item's reason restated. Annual panel. Age-appropriate priority review. |
| On any trigger | New medication, new condition, pregnancy, surgery, major life change, marker change. |
The quarterly removal trial is the mechanism that makes governance real rather than aspirational, because it forces one subtraction per quarter regardless of whether anything prompted it. Four per year is enough to keep a stack from accumulating indefinitely.
The annual audit is where age-appropriateness gets checked, and it is the review most likely to find something genuinely wrong. A protocol appropriate at 45 can be actively counterproductive at 70, particularly where it involves restriction.
The Triggers That Demand Immediate Review
Any new medication. The highest-priority trigger, because interaction risk is immediate and specific. Several supplements affect drug metabolism through CYP enzymes and transporters, and several affect bleeding, thyroid absorption or glycaemic control.
Planned surgery. Several supplements affect bleeding and should be discussed with the surgical team well in advance.
Pregnancy or planning pregnancy. Substantial changes required, and several common supplements are contraindicated.
A new clinical condition, particularly kidney or liver impairment, which changes the handling of many compounds.
Any unexplained marker change, particularly liver enzymes, which is a specific reason to review supplements, since several including high-dose green tea extract, ashwagandha and others have hepatotoxicity reports.
A resolved problem. The trigger most often ignored.
New evidence. A negative trial for something in your stack.
Age crossing a threshold where priorities invert, principally the point where lean mass preservation outranks metabolic optimisation.
How to Run a Removal Trial Properly
Choose the least-justified item, not the one you are most confident about. The point is to find what is not working.
Remove one thing. Not reduce, and not several.
Set a duration appropriate to the compound. Two to four weeks for anything with a short-term effect. Eight to twelve weeks for anything acting on a marker, with a re-measurement.
Define what you are watching before you start, so the conclusion is not retrospective.
Expect the first week to be misleading. Expectation effects are strongest immediately, and some compounds have a brief rebound that resolves.
Compare against your recent baseline, not your best period.
Accept the most common result, which is that nothing changes. That is a finding, and it means the item was not doing the work attributed to it.
Reintroduce only on evidence, and if you do, note what specifically returned when you stopped.
Governance as the Actual Product
There is a broader point here that applies beyond supplements.
Any protocol is a hypothesis about a person at a moment. The person changes, the moment passes, and the hypothesis needs revising. A protocol maintained without review is not a protocol, it is a habit that used to be a decision.
This is why governance rather than optimisation is the useful frame for a long horizon. Optimisation asks what the best stack is now. Governance asks how the stack will be kept matched to a person over thirty years, through changing evidence, changing biology, changing medication and changing priorities. The second question is harder and more consequential.
It also produces a different kind of discipline. The optimiser adds; the governor asks what should come off. Over a long enough horizon the governor ends up with a shorter, better-justified, safer and cheaper protocol, and, more importantly, one they can still explain.
The test is simple and worth applying annually: can you state, for each item, what it is for and what would make you stop? Anything failing that test has already stopped being a decision.
The AEONNN Perspective
This is the Shield architecture described directly. AEONNN's premise is that biology is never still, so a stack assembled once and held is drifting away from the person it was built for, and governance rather than optimisation is what a thirty-year horizon requires.
The platform's structural answer is the categorisation: corrective items address a problem that can resolve and get removal trials; maintenance items work by ongoing mechanism and stay while the effect is wanted; experimental items carry an observation window and a defined outcome. Without those categories a stack cannot be pruned, because nothing distinguishes an item still working from one whose reason lapsed.
The Safety layer holds the trigger list, and the highest-priority trigger is a new medication, since interaction risk is immediate and specific. Unexplained liver enzyme change is a specific reason to review supplements rather than to look elsewhere first. And the Insight Protocol handles removal as a first-class action, one per quarter, because the commercial gradient in this industry runs entirely toward addition and a platform that only ever adds is not reading the data it collects.
Pillar Matrix mapping
Database Matrix layers
- Meta / Consensus Layer (JAMA, BMJ, specialty society positions)
- Evidence Layer (PubMed, Cochrane, ClinicalTrials.gov)
- Safety Layer (DrugBank, FAERS)
- Real-Time User Layer (wearable and adherence signals)
Frequently Asked
Why do supplement stacks keep growing?
Improvements get attributed to additions while null results rarely remove anything, items have no expiry date, loss aversion discourages subtraction, and every commercial source has an interest in addition and none in subtraction.
How should each item in a stack be justified?
With a written reason: what problem, which marker or symptom, and what would indicate it worked. An item whose reason you cannot state is the first candidate for removal.
What are the three categories of stack item?
Corrective, addressing a problem that could resolve; maintenance, working by an ongoing mechanism that stops when it stops; and experimental, on trial with an observation window.
How often should a stack be reviewed?
Monthly for new medications and dose creep, quarterly for one removal trial, annually for a full audit with every item’s reason restated, and immediately on any trigger.
How do I run a removal trial?
Remove one item, choosing the least-justified one, for two to four weeks for short-acting compounds or eight to twelve with a re-measurement for marker-acting ones, with the outcome defined before starting.
What triggers an immediate review?
A new medication above all, plus planned surgery, pregnancy, a new clinical condition especially kidney or liver impairment, unexplained liver enzyme change, a resolved problem or a new negative trial.
What is the test of a well-governed stack?
Whether you can state, for each item, what it is for and what would make you stop. Anything failing that test has stopped being a decision.
Evidence and review
Any dosage ranges cited here reflect the ranges used in published human trials, not personal recommendations. Evidence in this field moves, so this article is reviewed quarterly and carries its last-updated date above. Nothing here is intended as medical advice, and supplementation should be discussed with a qualified clinician, particularly alongside prescribed medication or an existing condition.